Market Analysis: Global Hydronephrosis Market
The Global Hydronephrosis Market is accounted for USD 125.8 million in 2016 growing at a CAGR of 10.3% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Market Definition: Global Hydronephrosis Market
Hydronephrosis occurs due to the failure of normal drainage of urine from the kidney to the bladder and the kidney got swelled. Hydronephrosis results from some other underlying disorders.
Major Market Drivers and Restraints:
- Rising geriatric population
- Increasing prevalence of urinary infection and kidney diseases
- Increasing demand for advanced treatment
Market Segmentation: Global Hydronephrosis Market
By type, global hydronephrosis market is segmented into unilateral and bilateral.
On the basis of diagnosis, global hydronephrosis market is segmented into imaging and laboratory tests.
On the basis of treatment, global hydronephrosis market is segmented into shock wave lithotripsy, laparoscopy, bladder catheterization, steroid therapy and others.
On the basis of indication, global hydronephrosis market is segmented into intrinsic and extrinsic.
On the basis of end user the global hydronephrosis market is segmented into hospitals, specialty clinics, ambulatory surgical centers.
On the basis of geography, global hydronephrosis market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.
Competitive Analysis: Global Hydronephrosis Market
The global hydronephrosis market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of hydronephrosis market for global, Europe, North America, Asia Pacific and South America.
Major Market Competitors: Global Hydronephrosis Market
Some of the major players operating in global hydronephrosis market are NephroGenex, Inc., American Renal Associates, Phraxis, Inc., Renal Associates P.A., ALLERGAN, Amgen Inc., Anthem Bio Pharm, Sanofi, Novartis AG, EDAP TMS, Inceler Medikal Co. Ltd., Tenko Corporation Group, SILMAG, Smiths Medical, TROGE MEDICAL GmbH, GAMA GROUP, a.s., UROTECH, C. R. Bard, Inc. , Boston Scientific Corporation among others.
Research Methodology: Global Hydronephrosis Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.
Demand Side Primary Contributors: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.